Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in SVRA — Savara Inc

CIK 1423053 MIAMI, FL
Back to SVRA Full portfolio

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,361,092
-$309,094 QoQ
Shares Held
798,735
+3.1% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 184 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SVRA Over Time

Shares Held

Position Value (USD)

Derivatives in SVRA

reported options exposure · as of Mar 31, 2026
CallValue
$77,532
CallShares
14,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,537,601 across 374 Biotechnology names. SVRA ranks #136 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in SVRA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $77,532 14,200
2026-03-31 $4,361,092 798,735
2025-12-31 $4,670,186 774,492
2025-12-31 $177,885 29,500
2025-09-30 $2,385,138 668,106
2025-06-30 $31,920 14,000
2025-06-30 $252,587 110,784
2025-03-31 $106,645 38,500
2025-03-31 $11,357 4,100
2025-03-31 $1,396,110 504,011
2024-12-31 $109,599 35,700
2024-12-31 $1,842 600
2024-12-31 $532,324 173,396
2024-09-30 $52,152 12,300
2024-09-30 $172,568 40,700
2024-09-30 $1,340,641 316,189
2024-06-30 $648,858 161,007
2024-06-30 $459,420 114,000
2024-06-30 $369,954 91,800
2024-03-31 $25,896 5,200
2024-03-31 $1,992 400
2024-03-31 $42,872 8,609
2023-12-31 $798,717 169,940
2023-12-31 $13,160 2,800
2023-09-30 $74,031 19,585
2023-09-30 $4,536 1,200
2023-09-30 $15,498 4,100
2023-06-30 $29,394 9,200
2023-06-30 $50,139 15,693
2023-03-31 $152,749 78,333
2023-03-31 $22,425 11,500
2023-03-31 $13,845 7,100
2022-12-31 $61,244 39,513
2022-12-31 $75,640 48,800
2022-09-30 $28,039 18,090
2022-09-30 $32,550 21,000
2022-06-30 $23,104 15,200
2022-06-30 $49,434 32,523
2022-03-31 $54,627 41,700
2022-03-31 $16,468 12,571
2021-12-31 $67,332 54,300
2021-09-30 $16,836 12,200
2021-09-30 $82,524 59,800
2021-09-30 $42,472 30,777
2021-06-30 $118,830 69,900
2021-06-30 $56,100 33,000
2021-06-30 $72,276 42,516
2021-03-31 $116,480 56,000
2021-03-31 $203,008 97,600
2021-03-31 $308,212 148,179

Report a Problem

Category
Description
Email (optional, for follow-up)